135 related articles for article (PubMed ID: 31419511)
1. A Multigene Model for Predicting Tumor Responsiveness After Preoperative Chemoradiotherapy for Rectal Cancer.
Cho E; Park IJ; Yeom SS; Hong SM; Lee JB; Kim YW; Kim MJ; Lim HM; Lim SB; Yu CS; Kim JC
Int J Radiat Oncol Biol Phys; 2019 Nov; 105(4):834-842. PubMed ID: 31419511
[TBL] [Abstract][Full Text] [Related]
2. Gene and MicroRNA Expression Are Predictive of Tumor Response in Rectal Adenocarcinoma Patients Treated With Preoperative Chemoradiotherapy.
Millino C; Maretto I; Pacchioni B; Digito M; De Paoli A; Canzonieri V; D'Angelo E; Agostini M; Rizzolio F; Giordano A; Barina A; Rajendran S; Esposito G; Lanfranchi G; Nitti D; Pucciarelli S
J Cell Physiol; 2017 Feb; 232(2):426-435. PubMed ID: 27225591
[TBL] [Abstract][Full Text] [Related]
3. Circulating miRNA Signature Predicts Response to Preoperative Chemoradiotherapy in Locally Advanced Rectal Cancer.
Wada Y; Shimada M; Morine Y; Ikemoto T; Saito Y; Zhu Z; Wang X; Etxart A; Park Y; Bujanda L; Park IJ; Goel A
JCO Precis Oncol; 2021; 5():. PubMed ID: 34913022
[TBL] [Abstract][Full Text] [Related]
4. Serum miR-125b is a non-invasive predictive biomarker of the pre-operative chemoradiotherapy responsiveness in patients with rectal adenocarcinoma.
D'Angelo E; Fassan M; Maretto I; Pucciarelli S; Zanon C; Digito M; Rugge M; Nitti D; Agostini M
Oncotarget; 2016 May; 7(19):28647-57. PubMed ID: 27081702
[TBL] [Abstract][Full Text] [Related]
5. Biomarker-Based Scoring System for Prediction of Tumor Response After Preoperative Chemoradiotherapy in Rectal Cancer by Reverse Transcriptase Polymerase Chain Reaction Analysis.
Hur H; Tulina I; Cho MS; Min BS; Koom WS; Lim JS; Ahn JB; Kim NK
Dis Colon Rectum; 2016 Dec; 59(12):1174-1182. PubMed ID: 27824703
[TBL] [Abstract][Full Text] [Related]
6. A Nine-Gene Signature for Predicting the Response to Preoperative Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer.
Park IJ; Yu YS; Mustafa B; Park JY; Seo YB; Kim GD; Kim J; Kim CM; Noh HD; Hong SM; Kim YW; Kim MJ; Ansari AA; Buonaguro L; Ahn SM; Yu CS
Cancers (Basel); 2020 Mar; 12(4):. PubMed ID: 32225122
[TBL] [Abstract][Full Text] [Related]
7. Telomere-specific reverse transcriptase (hTERT) and cell-free RNA in plasma as predictors of pathologic tumor response in rectal cancer patients receiving neoadjuvant chemoradiotherapy.
Pucciarelli S; Rampazzo E; Briarava M; Maretto I; Agostini M; Digito M; Keppel S; Friso ML; Lonardi S; De Paoli A; Mescoli C; Nitti D; De Rossi A
Ann Surg Oncol; 2012 Sep; 19(9):3089-96. PubMed ID: 22395986
[TBL] [Abstract][Full Text] [Related]
8. High Expression of VSTM2L Induced Resistance to Chemoradiotherapy in Rectal Cancer through Downstream IL-4 Signaling.
Liu H; Zhang Z; Zhen P; Zhou M
J Immunol Res; 2021; 2021():6657012. PubMed ID: 33506057
[TBL] [Abstract][Full Text] [Related]
9. A functional biological network centered on XRCC3: a new possible marker of chemoradiotherapy resistance in rectal cancer patients.
Agostini M; Zangrando A; Pastrello C; D'Angelo E; Romano G; Giovannoni R; Giordan M; Maretto I; Bedin C; Zanon C; Digito M; Esposito G; Mescoli C; Lavitrano M; Rizzolio F; Jurisica I; Giordano A; Pucciarelli S; Nitti D
Cancer Biol Ther; 2015; 16(8):1160-71. PubMed ID: 26023803
[TBL] [Abstract][Full Text] [Related]
10. Role of genetic polymorphisms in NFKB-mediated inflammatory pathways in response to primary chemoradiation therapy for rectal cancer.
Dzhugashvili M; Luengo-Gil G; García T; González-Conejero R; Conesa-Zamora P; Escolar PP; Calvo F; Vicente V; Ayala de la Peña F
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):595-602. PubMed ID: 25304949
[TBL] [Abstract][Full Text] [Related]
11. Improvement in the Assessment of Response to Preoperative Chemoradiotherapy for Rectal Cancer Using Magnetic Resonance Imaging and a Multigene Biomarker.
Cho E; Jung SW; Park IJ; Jang JK; Park SH; Hong SM; Lee JL; Kim CW; Yoon YS; Lim SB; Yu CS; Kim JC
Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298695
[TBL] [Abstract][Full Text] [Related]
12. Total Mesorectal Excision Versus Local Excision After Favorable Response to Preoperative Chemoradiotherapy in "Early" Clinical T3 Rectal Cancer: A Propensity Score Analysis.
Shin YS; Yu CS; Park JH; Kim JC; Lim SB; Park IJ; Kim TW; Hong YS; Kim KP; Yoon SM; Joo JH; Kim JH
Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):136-144. PubMed ID: 28816139
[TBL] [Abstract][Full Text] [Related]
13. Predicting multi-class responses to preoperative chemoradiotherapy in rectal cancer patients.
Gim J; Cho YB; Hong HK; Kim HC; Yun SH; Wu HG; Jeong SY; Joung JG; Park T; Park WY; Lee WY
Radiat Oncol; 2016 Mar; 11():50. PubMed ID: 27005571
[TBL] [Abstract][Full Text] [Related]
14. Diffusion-weighted MRI and MR- volumetry--in the evaluation of tumor response after preoperative chemoradiotherapy in patients with locally advanced rectal cancer.
Birlik B; Obuz F; Elibol FD; Celik AO; Sokmen S; Terzi C; Sagol O; Sarioglu S; Gorken I; Oztop I
Magn Reson Imaging; 2015 Feb; 33(2):201-12. PubMed ID: 25460330
[TBL] [Abstract][Full Text] [Related]
15. Association of thymidylate synthase polymorphisms with the tumor response to preoperative chemoradiotherapy in rectal cancer: a systematic review and meta-analysis.
Yang YC; Wu GC; Jin L; Wang KL; Bai ZG; Wang J; Zhang ZT
Pharmacogenomics J; 2017 Jun; 17(3):265-273. PubMed ID: 27001118
[TBL] [Abstract][Full Text] [Related]
16. Ratio of metastatic lymph nodes is more important for rectal cancer patients treated with preoperative chemoradiotherapy.
Park IJ; Yu CS; Lim SB; Yoon YS; Kim CW; Kim TW; Kim JH; Kim JC
World J Gastroenterol; 2015 Mar; 21(11):3274-81. PubMed ID: 25805934
[TBL] [Abstract][Full Text] [Related]
17. Quantitative analysis of diffusion weighted imaging to predict pathological good response to neoadjuvant chemoradiation for locally advanced rectal cancer.
Tang Z; Zhang XY; Liu Z; Li XT; Shi YJ; Wang S; Fang M; Shen C; Dong E; Sun YS; Tian J
Radiother Oncol; 2019 Mar; 132():100-108. PubMed ID: 30825957
[TBL] [Abstract][Full Text] [Related]
18. miR-194 as predictive biomarker of responsiveness to neoadjuvant chemoradiotherapy in patients with locally advanced rectal adenocarcinoma.
D'Angelo E; Zanon C; Sensi F; Digito M; Rugge M; Fassan M; Scarpa M; Pucciarelli S; Nitti D; Agostini M
J Clin Pathol; 2018 Apr; 71(4):344-350. PubMed ID: 28870889
[TBL] [Abstract][Full Text] [Related]
19. Prediction of response to preoperative chemoradiotherapy in rectal cancer by using reverse transcriptase polymerase chain reaction analysis of four genes.
Watanabe T; Kobunai T; Akiyoshi T; Matsuda K; Ishihara S; Nozawa K
Dis Colon Rectum; 2014 Jan; 57(1):23-31. PubMed ID: 24316942
[TBL] [Abstract][Full Text] [Related]
20. Predicting response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer with serum biomarkers.
Clarke TL; White DA; Osborne ME; Shaw AM; Smart NJ; Daniels IR
Ann R Coll Surg Engl; 2017 May; 99(5):373-377. PubMed ID: 28462648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
